Therefore, CRC patients with high CD26 expression may fail to eradicate the CD26+ cells under chemotherapeutic treatments which led to enrichment of CD26+ cells and ultimately cause further metastasis and worse survival after first year of treatment. Here, DPP4 is linked to colorectal carcinoma.